17β-estradiol modulates expression of low-voltage-activated Ca v3.2 T-type calcium channel via extracellularly regulated kinase pathway in cardiomyocytes

Endocrinology

Volumn 150, Issue 2, 2009, Pages 879-888

  Marni, Farzana ^a   Wang, Yan ^a   Morishima, Masaki ^a   Shimaoka, Toru ^a   Uchino, Tomoko ^a   Zheng, Mingqi ^a   Kaku, Toshihiko ^a   Ono, Katsushige ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; ESTRADIOL; ESTROGEN RECEPTOR; MESSENGER RNA; PHOSPHOTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HEART MUSCLE CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ANIMALS; CALCIUM CHANNELS, T-TYPE; CELLS, CULTURED; ELECTROPHYSIOLOGY; ESTRADIOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; HEART RATE; HUMANS; MYOCYTES, CARDIAC; OVARIECTOMY; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 59649094669     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0645     Document Type: Article

References (59)

1. 2+ channels in cardiac pace- making. J Pharmacol Sci 99:197-204
2. Perez-Reyes E 2003 Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83:117-161
3. 2+ channels in the heart. Cell Calcium 40:205-220
4. 2+ channels in neonatal rat heart. J Mol Cell Cardiol 42:1045-1053
5. Leuranguer V, Monteil A, Bourinet E, Dayanithi G, Nargeot J 2000 T-type calcium currents in rat cardiomyocytes during postnatal development: contribution to hormone secretion. Am J Physiol 279:H2540-H2548
6. Hu K, Qu Y, Yue Y, Boutjdir M 2004 Functional basis of sinus bradycardia in congenital heart block. Circ Res 94:e32-e38
7. BaruscottiM, BucchiA, DifrancescoD2005 Physiology and pharmacology of the cardiac pacemaker ("funny") current. Pharmacol Ther 107:59-79
8. Stieber J, Herrmann S, Feil S, Loster J, Feil R, Biel M, Hofmann F, Ludwig A 2003 The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart. Proc Natl Acad Sci USA 100:15235-15240
9. 2+ current to electrical activity in sinoatrial nodal myocytes of rabbits. Am J Physiol 1276:H1064-H1077
10. Zhang Z, Xu Y, Song H, Rodriguez J, Tuteja D, Namkung Y, Shin HS, Chiamvimonvat N 2002 Functional roles of Cav1.3 α 1D calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice. Circ Res 90:981-987
11. 2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci USA 100:5543-5548
12. 2+ channels in ventricular cells from hypertrophied rat hearts. J Mol Cell Cardiol 31:1617-1625
13. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 73:777-782
14. 2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ Res 75:149-155
15. 2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. Circulation 100:2191-2197
16. Babiker FA, De Windt LJ, van Eickels M, Grohe C, Meyer R, Doevendans PA 2002 Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc Res 53:709-719
17. Barrett-Connor E 1997 Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 95:252-264
18. Mendelsohn ME, Karas RH 2005 Molecular and cellular basis of cardiovascular gender differences. Science 308:1583-1587
19. Hall JM, Couse JF, KorachKS 2001 Themultifacetedmechanisms ofestradiol and estrogen receptor signaling. J Biol Chem 276:36869-36872
20. Ueyama T, Ishikura F, Matsuda A, Asanuma T, Ueda K, Ichinose M, Kasamatsu K, Hano T, Akasaka T, Tsuruo Y, Morimoto K, Beppu S 2007 Chronic estrogen supplementation following ovariectomy improves the emotional stress -induced cardiovascular responses by indirect action on the nervous system and by direct action on the heart. Circ J 71:565-573
21. van Eickels M, Grohé C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA 2001 17α3-Estradiol attenuates the development of pressure-overload hypertrophy. Circulation 104:1419-1423
22. Saleh MC, Connell BJ, Saleh TM 2000 Autonomic and cardiovascular reflex responses to central estrogen injection in ovariectomized female rats. Brain Res 879:105-114
23. v1.2. Biochem Biophys Res Commun 361:522-527
24. KorovkinaVP,BrainardAM,IsmailP,SchmidtTJ,EnglandSK2004Estradiol binding to maxi-K channels induces their down-regulation via proteasomal degradation. J Biol Chem 279:1217-1223
25. Fatehi M, Kombian SB, Saleh TM 2005 17β-Estradiol inhibits outward potassium currents recorded in rat parabrachial nucleus cells in vitro. Neuro-science 135:1075-1086
26. Nakajima T, Iwasawa K, Oonuma H, Morita T, Goto A, Wang Y, Hazama H 1999 Antiarrythmiceffectanditsunderlyingionicmechanismof17β-estradiol in cardiac myocytes. Br J Pharmacol 127:429 -440
27. ATP channels in heart-derived H9c2 cells. J Am Coll Cardiol 40:367-374
28. Furukawa T, Bai CX, Kaihara A, Ozaki E, Kawano T, Nakaya Y, Awais M, Sato M, Umezawa Y, Kurokawa J 2006 Ginsenoside Re, a main phytosterol of Panax ginseng, activates cardiac potassium channels via a nongenomic pathway of sexhormones. Mol Pharmacol 70:1916-1924
29. Ichinose M, Yonemochi H, Sato T, Saikawa T 2003 Diazoxide triggers car- dioprotection against apoptosis induced by oxidative stress. Am J Physiol Heart Circ Physiol 284:H2235-H2241
30. 2+ channel through distinct mechanisms. Mol Pharmacol 69:1684-1691
31. 2+ channel current expressed in HEK-293 cells. Pharmacology 76:192-200
32. Akazawa H, Komuro I 2005 Cardiac transcription factor Csx/Nkx2-5: its role in cardiac development and diseases. Pharmacol Ther 107:252-268
33. 1receptorandsaltsensitivity. Hypertension 42:1157-1163
34. Hinojosa-Laborde C, Craig T, Zheng W, Ji H, Haywood JR, Sandberg K 2004 Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension 44:405-409
35. Chappell MC, Gallagher PE, Averill DB, Ferrario CM, BrosnihanKB2003 Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2.Lewis rat. Hypertension 42:781-786
36. Brockbank CL, Chatterjee F, Bruce SA, Woledge RC 2000 Heart rate and its variability change after the menopause. Exp Physiol 85:327-330
37. Ji H, Zheng Y, Falconetti C, Roesch DM, Mulroney SE, Sandberg K 2007 17β-Estradiol deficiencyreduces potassium excretion in an angiotensin type 1 receptor-dependent manner. Am JPhysiol Heart Circ Physiol 293:H17-H22
38. Fülöp L, Bányász T, Szabó G, Tóth IB, BíróT, Lôrincz I, Balogh A, Petô K, Mikó I, Nánási PP 2006 Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs. Acta Physiol 188:163-171
39. Ito K, Hirooka Y, Kimura Y, Sagara Y, Sunagawa K 2006 Ovariectomy augments hypertension through Rho-kinase activation in the brain stem in female spontaneously hypertensive rats. Hypertension 48:651-657
40. Hinojosa-Laborde C, Lange DL, Haywood JR 2000 Role of female sex hormones in the development and reversal of Dahl hypertension. Hypertension 35:484-489
41. Meyer R, Linz KW, Surges R, Meinardus S, Vees J, Hoffmann A, Windholz O, Grohé C 1998 Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat. Exp Physiol 83:305-321
42. Qiu J, Bosch MA, Jamali K, Xue C, Kelly MJ, Rønnekleiv OK 2006 Estrogen upregulatesT-type calcium channels in the hypothalamus and pituitary. JNeu- rosci 26:11072-11082
43. Mangoni ME, Traboulsie A, Leoni AL, Couette B, Marger L, Le Quang K, Kupfer E, Cohen-Solal A, Vilar J, Shin HS, Escande D, Charpentier F, Nargeot J, Lory P 2006 Bradycardia and slowing of the atrioventricular conduction in mice lacking Cav3.1/α1G T-type calcium channels. Circ Res 98:1422-1430
44. Orito K, SatohK, Taira N1993 Cardiovascular profile ofRo 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts. J Cardiovasc Pharmacol 22:293-299
45. Véniant M, Clozel JP, Hess P, Wolfqanq R 1991 Ro 40-5967, in contrast to diltiazem, does not reduce left ventricular contractility in rats with chronic myocardial infarction. J Cardiovasc Pharmacol 17:277-284
46. Lalevée N, Rebsamen MC, Barr̀re-Lemaire S, Perrier E, Nargeot J, Béenitah JP, Rossier MF 2005 Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes. Cardiovasc Res 67:216-224
47. MichelsG,ErF, Eicks M, Herzig S, Hoppe UC2006 Long-term and immediate effect of testosterone on single T-type calcium channel in neonatal rat cardi- omyocytes. Endocrinology 147:5160 -5169
48. Hawkins MB, Thornton JW, Crews D, Skipper JK, Dotte A, Thomas P 2000 Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts. Proc Natl Acad Sci USA 97:10751-10756
49. Grohé C, Kahlert S, Löbbert K, Stimpel M, Karas RH, Vetter H, Neyses L 1997 Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416:107-112
50. Pedram A, Razandi M, Aitkenhead M, Levin ER 2005 Estrogen inhibits car- diomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1. J Biol Chem 280:26339-26348
51. Nuedling S, Kahlert S, LoebbertK, Doevendans PA, Meyer R, Vetter H, Grohé C 1999 17β-Estradiol stimulates expression of endothelial and inducible NO synthasein ratmyocardium in-vitro and in-vivo. CardiovascRes 43:666-674
52. Coiret G, Matifat F, Hague F, Ouadid-Ahidouch H 2005 17-β-Estradiol activates maxi-K channels through a non-genomic pathway in human breast cancer cells. FEBS Lett 579:2995-3000
53. Guo RX, Wei LH, Tu Z, Sun PM, Wang JL, Zhao D, Li XP, Tang JM 2006 17/ -Estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells. J Steroid Biochem Mol Biol 99:9-18
54. Leung SW, Teoh H, Keung W, Man RY 2007 Non-genomic vascular actions of female sex hormones: physiological implications and signalling pathways. Clin Exp Pharmacol Physiol 34:822-826
55. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF2006 Avariant of estrogen receptor-α, hER-α36: transduction of estrogen- and antiestrogen- dependent membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA 103:9063-9068
56. Leung YK, Mak P, HassanS, Ho SM 2006 Estrogen receptor (ER)-βisoforms: a key to understanding ER-βsignaling. Proc Natl Acad Sci USA 103:13162-13167
57. Couse JF, KorachKS 1999 Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20:358 -417
58. Bueno OF, Molkentin JD 2002 Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91:776-781
59. 2+ channel- regulationofCACNA1Hbyneuron-restrictivesilencerfactor. JPharmacolSci 99:211-213